Anti-ULBP2 antibody [EPR22303-124]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(5 Publications)
Rabbit Recombinant Monoclonal ULBP2 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 5 publications.
View Alternative Names
N2DL2, RAET1H, UNQ463/PRO791, ULBP2, UL16-binding protein 2, ALCAN-alpha, NKG2D ligand 2, Retinoic acid early transcript 1H, N2DL-2, NKG2DL2
- IP
Unknown
Immunoprecipitation - Anti-ULBP2 antibody [EPR22303-124] (AB275023)
ULBP2 was immunoprecipitated from 0.35 mg BxPC-3 (human pancreas adenocarcinoma epithelial cell), whole cell lysate with ab275023 at 1/30 dilution (2μg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab275023 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : BxPC-3 whole cell lysate 10 μg
Lane 2 : ab275023 IP in BxPC-3 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab275023 inBxPC-3 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 5.5 seconds.
All lanes:
Immunoprecipitation - Anti-ULBP2 antibody [EPR22303-124] (ab275023)
Predicted band size: 27 kDa
Observed band size: 27 kDa
false
- WB
Supplier Data
Western blot - Anti-ULBP2 antibody [EPR22303-124] (AB275023)
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure times : Lane 1 : 10 seconds Lane 2-7 : 3 minutes.
Negative control : Raji, Daudi (PMID : 12414645).
All lanes:
Western blot - Anti-ULBP2 antibody [EPR22303-124] (ab275023) at 1/1000 dilution
Lane 1:
BxPC-3 (human pancreas adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 2:
MOLT-4 (human lymphoblastic leukemia T lymphoblast), whole cell lysate at 20 µg
Lane 3:
Raji (human Burkitt's lymphoma B lymphocyte), whole cell lysate at 20 µg
Lane 4:
Daudi (human Burkitt's lymphoma lymphoblast), whole cell lysate at 20 µg
Lane 5:
HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 6:
HCT116 (human colorectal carcinoma epithelial cell), whole cell lysate at 20 µg
Lane 7:
U-87 MG (human glioblastoma-astrocytoma epithelial cell), whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 27 kDa
Observed band size: 27 kDa
false
Related conjugates and formulations (1)
-
Anti-ULBP2 antibody [EPR22303-124] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The function of ULBP2 is to facilitate the activation of natural killer (NK) cells and cytotoxic T lymphocytes through binding to the NKG2D receptor. ULBP2 is not a part of a complex but acts independently to trigger immune responses. By interacting with NKG2D ULBP2 promotes the release of cytokines and enhances the cytolytic activity of these immune cells leading to the destruction of infected or transformed cells. This mechanism allows the immune system to efficiently target and eliminate compromised cells.
Pathways
The interaction between ULBP2 and the NKG2D receptor forms a critical part of the immune surveillance pathway. This pathway detects and responds to cellular abnormalities such as tumorigenesis or viral infections. ULBP2's activity relates closely with other NKG2D ligands and components of the immune checkpoint pathways notably involving proteins like MICA and MICB. Additionally ULBP2’s interaction impacts the balance between activating and inhibitory signals within the NK cell cascade thereby influencing immune system homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Cell death & disease 16:597 PubMed40775202
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 16:1515605 PubMed39963142
2025
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 29:15 PubMed39492940
2024
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 10:e34221 PubMed39082023
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of ethnopharmacology 275:114175 PubMed33933571
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com